Phase I trial of GRC 15300 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2011
At a glance
- Drugs GRC 15300 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions; Pharmacokinetics
- 25 Jul 2011 Status changed from planning to completed.
- 19 Feb 2009 New trial record.